Market Overview

UPDATE: Barrington Reiterates Outperform Rating, $650 PT on Intuitive Surgical

Share:
Related ISRG
Barclays Thinks Intuitive Surgical Is Still Worth $650
Stocks Hitting 52-Week Highs
Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth (Investor's Business Daily)

In a report published Friday, Barrington reiterated its Outperform rating and $650.00 price target on Intuitive Surgical (NASDAQ: ISRG).

Barrington noted, “We are reiterating our OUTPERFORM rating and $650 price target following ISRG's Q4/12 earnings as we believe management will continue to execute on its significant market opportunities over the short and long term and will drive strong procedure growth/pricing power with new technologies in new procedures. We believe the short reports circulated recently are largely based on unfounded concerns and we expect the patient and hospital demand for da Vinci procedures to remain high in the face of the issues highlighted in those reports.”

Intuitive Surgical closed on Thursday at $576.07.

Latest Ratings for ISRG

DateFirmActionFromTo
Jan 2016Morgan StanleyUpgradesEqual-weightOverweight
Nov 2015CitigroupInitiates Coverage onBuy
Jul 2015Canaccord GenuityUpgradesBuy

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: BarringtonAnalyst Color Reiteration Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!

Get Benzinga's Newsletters